Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease

Journal of the American College of Cardiology

Volumn 27, Issue 7, 1996, Pages 1555-1561

  Muhlestein, Joseph B ^a,b   Hammond, Elizabeth H ^a   Carlquist, John F ^a   Radicke, Ellen ^a   Thomson, Matthew J ^a   Karagounis, Labros A ^a   Woods, Marion L ^a   Anderson, Jeffrey L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b LDS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATHERECTOMY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BACTERIAL COLONIZATION; CARDIOVASCULAR DISEASE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERODIAGNOSIS; THROMBOCYTE ADHESION; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0030000143     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00055-1     Document Type: Article

References (27)

1. National Heart, Lung, and Blood Institute. Vital Statistics of the United States. Rockville, MD: National Center for Health Statistics, 1986.
2. Working Group on Arteriosclerosis of the National Heart, Lung, and Blood Institute. Report of the Working Group on Arteriosclerosis of the National Heart, Lung, and Blood Institute - Summary, Conclusions, and, Recommendations, Vol 1. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health, NIH Publication No 81-2034, June 1981.
3. Working Group on Arteriosclerosis of the National Heart, Lung, and Blood Institute. Report of the Working Group on Arteriosclerosis of the National Heart, Lung, and Blood Institute, Vol 2. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health, NIH Publication No 81-2035, Sept 1981.
4. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991;324(15):1043-8.
5. Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990;161:618-625.
6. Leinonen M. Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. Eur Heart J 1993;14(Suppl K):57-61.
7. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992;116:273-8.
8. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-5.
9. Thom DH, Wang SP, Grayston JT, et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991;11:547-51.
10. Thom DH, Grayston JT, Siscovick Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992;268:68-72.
11. Haidl S, Juul-Moller S, Israelsson B, Persson K. Ischemic heart disease and antibodies to Chlamydia pneumoniae (TWAR). Proc Symp Eur Soc Chlamydia Res Uppsala: Centre for STD Res, Uppsala University, 1992;2:174.
12. Saikku P. Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. Eur Heart J 1993;14(Suppl K):62-5.
13. Linnanmaki E, Leinonen M, Mattila K, Nieminen MS, Viltonen V, Saikku P. Chlamydia pneumoniae - specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993;87:1130-4.
14. Kuo C-C, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-9.
15. Shor A, Kuo C-C, Patton DL. Detection of Chlamydia pneumoniae in the coronary artery atheroma plaque. S African Med J 1992;82:158-161.
16. Grayston JT, Kuo CC, Coulson AS, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995;92(12):3397-400.
17. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 1995;19(15):6911-4.
18. Yang ZP, Cummings PK, Patton DL, Kuo C-C. Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis. J Infect Dis 1994;170:464-7.
19. Lower RR, Kontos HA, Kosek JC, Sewell DH, Graham WH. Experiences in heart transplantation: technic, physiology, and rejection. Am J Cardiol 1968;22:766-72.
20. Caplan M, Hastillo A, Mohamakumar T. Immunologic mechanisms in the atherosclerotic process. Cardiovasc Rev 1984;5:713-8.
21. Safian RD, Gelbfish JS, Erny RE, Schnitt SJ, Schmidt DA, Baim DS. Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation 1990;82(1):69-79.
22. Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect 1992;25(Suppl 1):27-34.
23. Wissler RW. Update on the pathogenesis of atherosclerosis. Am J Med 1991;91(Suppl 1B):S3-9.
24. Raines EW, Ross RR. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J 1993;69:S30-7.
25. Lorant DE, Topham MK, Whatley RE, et al. Inflammatory roles of P-selectin. J Clin Invest 1993;92:559-70.
26. Fryer RH, Woods ML, Rodgers GM. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity (abstract). Clin Res 1994;42:83A.
27. Moxon ER. Microbes, molecules and man. The Mitchell Lecture 1992. J R Coll Physicians Lond 1993;27(2):169-74.